vs
Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Inogen Inc (INGN). Click either name above to swap in a different company.
CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $68.6M, roughly 2.0× Inogen Inc). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 3.4%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 4.2%).
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
CTRE vs INGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $134.9M | $68.6M |
| Net Profit | $111.3M | — |
| Gross Margin | — | 51.4% |
| Operating Margin | — | -13.6% |
| Net Margin | 82.5% | — |
| Revenue YoY | 55.1% | 3.4% |
| Net Profit YoY | 113.5% | — |
| EPS (diluted) | $0.52 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $134.9M | $68.6M | ||
| Q3 25 | $132.4M | $79.1M | ||
| Q2 25 | $112.5M | $79.2M | ||
| Q1 25 | $96.6M | $68.5M | ||
| Q4 24 | $86.9M | $66.3M | ||
| Q3 24 | $77.4M | $74.9M | ||
| Q2 24 | $68.9M | $74.4M | ||
| Q1 24 | $63.1M | $63.1M |
| Q4 25 | $111.3M | — | ||
| Q3 25 | $74.9M | $-5.3M | ||
| Q2 25 | $68.5M | $-4.2M | ||
| Q1 25 | $65.8M | $-6.2M | ||
| Q4 24 | $52.1M | — | ||
| Q3 24 | $33.4M | $-6.0M | ||
| Q2 24 | $10.8M | $-5.6M | ||
| Q1 24 | $28.7M | $-14.6M |
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 52.2% | ||
| Q1 25 | — | 53.1% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | — | 55.2% | ||
| Q2 24 | — | 57.4% | ||
| Q1 24 | — | 54.5% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | 58.1% | -9.0% | ||
| Q2 25 | 61.3% | -7.7% | ||
| Q1 25 | — | -11.2% | ||
| Q4 24 | — | -17.2% | ||
| Q3 24 | 43.0% | -10.4% | ||
| Q2 24 | 15.1% | -9.5% | ||
| Q1 24 | — | -25.8% |
| Q4 25 | 82.5% | — | ||
| Q3 25 | 56.6% | -6.7% | ||
| Q2 25 | 60.9% | -5.2% | ||
| Q1 25 | 68.1% | -9.0% | ||
| Q4 24 | 60.0% | — | ||
| Q3 24 | 43.2% | -8.0% | ||
| Q2 24 | 15.6% | -7.5% | ||
| Q1 24 | 45.6% | -23.1% |
| Q4 25 | $0.52 | $-0.26 | ||
| Q3 25 | $0.35 | $-0.20 | ||
| Q2 25 | $0.35 | $-0.15 | ||
| Q1 25 | $0.35 | $-0.25 | ||
| Q4 24 | $0.30 | $-0.41 | ||
| Q3 24 | $0.21 | $-0.25 | ||
| Q2 24 | $0.07 | $-0.24 | ||
| Q1 24 | $0.22 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.0M | $103.7M |
| Total DebtLower is stronger | $894.2M | — |
| Stockholders' EquityBook value | $4.0B | $192.2M |
| Total Assets | $5.1B | $298.6M |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.0M | $103.7M | ||
| Q3 25 | $712.5M | $106.5M | ||
| Q2 25 | $306.1M | $103.7M | ||
| Q1 25 | $26.5M | $118.9M | ||
| Q4 24 | $213.8M | $113.8M | ||
| Q3 24 | $377.1M | $105.7M | ||
| Q2 24 | $495.1M | $97.9M | ||
| Q1 24 | $451.2M | $107.4M |
| Q4 25 | $894.2M | — | ||
| Q3 25 | $893.8M | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $822.1M | — | ||
| Q4 24 | $396.9M | — | ||
| Q3 24 | $396.7M | — | ||
| Q2 24 | $671.1M | — | ||
| Q1 24 | $595.9M | — |
| Q4 25 | $4.0B | $192.2M | ||
| Q3 25 | $4.0B | $197.2M | ||
| Q2 25 | $3.3B | $199.5M | ||
| Q1 25 | $2.9B | $198.0M | ||
| Q4 24 | $2.9B | $173.9M | ||
| Q3 24 | $2.4B | $185.4M | ||
| Q2 24 | $1.9B | $187.6M | ||
| Q1 24 | $1.7B | $191.9M |
| Q4 25 | $5.1B | $298.6M | ||
| Q3 25 | $5.1B | $307.0M | ||
| Q2 25 | $4.7B | $312.0M | ||
| Q1 25 | $3.9B | $308.4M | ||
| Q4 24 | $3.4B | $296.2M | ||
| Q3 24 | $2.9B | $306.2M | ||
| Q2 24 | $2.7B | $308.9M | ||
| Q1 24 | $2.3B | $315.6M |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $394.0M | $-943.0K |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 3.54× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $394.0M | $-943.0K | ||
| Q3 25 | $100.9M | $2.2M | ||
| Q2 25 | $100.8M | $4.3M | ||
| Q1 25 | $71.4M | $-16.8M | ||
| Q4 24 | $244.3M | $-3.0M | ||
| Q3 24 | $67.2M | $7.0M | ||
| Q2 24 | $53.0M | $6.7M | ||
| Q1 24 | $48.8M | $-4.7M |
| Q4 25 | — | $-1.9M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-17.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $-6.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | -24.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | -9.6% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 3.54× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 4.68× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRE
Segment breakdown not available.
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
